AT396266T - Trp8 cancer marker - Google Patents

Trp8 cancer marker

Info

Publication number
AT396266T
AT396266T AT01967204T AT01967204T AT396266T AT 396266 T AT396266 T AT 396266T AT 01967204 T AT01967204 T AT 01967204T AT 01967204 T AT01967204 T AT 01967204T AT 396266 T AT396266 T AT 396266T
Authority
AT
Austria
Prior art keywords
trp8
cancer marker
marker
cancer
Prior art date
Application number
AT01967204T
Other languages
German (de)
Inventor
Ulrich Wissenbach
Original Assignee
Ulrich Wissenbach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22151300P priority Critical
Application filed by Ulrich Wissenbach filed Critical Ulrich Wissenbach
Publication of AT396266T publication Critical patent/AT396266T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
AT01967204T 2000-07-28 2001-07-18 Trp8 cancer marker AT396266T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US22151300P true 2000-07-28 2000-07-28

Publications (1)

Publication Number Publication Date
AT396266T true AT396266T (en) 2008-06-15

Family

ID=22828139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01967204T AT396266T (en) 2000-07-28 2001-07-18 Trp8 cancer marker

Country Status (8)

Country Link
US (1) US7205108B2 (en)
EP (1) EP1366158B1 (en)
JP (1) JP2004505617A (en)
AT (1) AT396266T (en)
AU (1) AU8763901A (en)
CA (1) CA2417671A1 (en)
DE (1) DE60134178D1 (en)
WO (1) WO2002010382A2 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364867B2 (en) 2000-04-17 2008-04-29 The Mount Sinai School Of Medicine Method of identifying bitter compounds by employing TRP8, a transient receptor potential channel expressed in taste receptor cells
DE10215321A1 (en) * 2002-04-02 2003-10-23 Metagen Pharmaceuticals Gmbh New nucleic acid encoding Trpp8 splice variants, useful for diagnosis of prostatic cancer, and to screen for diagnostic or therapeutic agents, also related proteins
AU2003226797A1 (en) * 2002-04-16 2003-10-27 Bayer Healthcare Ag Regulation of human transient receptor potential channel
AU2003241299A1 (en) * 2002-04-19 2003-11-03 Schering Aktiengesellschaft Novel prostate tumor-specific promoter
JP4431503B2 (en) * 2003-01-08 2010-03-17 日本ミルクコミュニティ株式会社 Factors that promote calcium absorption
SG195524A1 (en) 2003-11-06 2013-12-30 Seattle Genetics Inc Monomethylvaline compounds capable of conjugation to ligands
NZ579482A (en) 2004-06-01 2011-02-25 Genentech Inc Antibody drug conjugates and methods
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
BRPI0516284A (en) 2004-09-23 2008-09-02 Genentech Inc Built antibody with cysteine, a method to select antibodies, conjugates of antibody-drug, pharmaceutical composition, method of killing or inhibiting tumor cell proliferation, methods of inhibiting cell proliferation and tumor cell growth, article of manufacture and method to produce a compound
WO2007053570A2 (en) * 2005-10-31 2007-05-10 Janssen Pharmaceutica N.V. A polypeptide complex of trpm8 and calmodulin and its uses thereof
JP5749154B2 (en) 2008-03-19 2015-07-15 ソリシメド・バイオファーマ・インコーポレーテッド Trpv6 peptide compositions for the treatment of cancer by calcium channel activity inhibition
MX2012000086A (en) * 2009-06-26 2012-06-12 Soricimed Biopharma Inc Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery.
WO2011031870A1 (en) 2009-09-09 2011-03-17 Centrose, Llc Extracellular targeted drug conjugates
AU2011239507B2 (en) 2010-04-15 2015-04-09 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
AU2011265054B2 (en) 2010-06-08 2016-09-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
ES2544608T3 (en) 2010-11-17 2015-09-02 Genentech, Inc. Conjugates of the antibody and alaninyl-maytansinol
RU2638806C2 (en) 2011-05-12 2017-12-15 Дженентек, Инк. Lc-ms/ms method for multiple reactions monitoring to identify therapeutic antibodies in animal species using framework signature peptides
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
CN105050661B (en) 2012-10-12 2018-03-30 Adc疗法责任有限公司 Pyrrolo benzodiazepine - antibody conjugate
KR20150085814A (en) 2012-10-12 2015-07-24 에이디씨 테라퓨틱스 에스에이알엘 Pyrrolobenzodiazepine-antibody conjugates
JP5993093B2 (en) 2012-10-12 2016-09-14 メドイミューン・リミテッドMedImmune Limited Pyrrolo benzodiazepines and their complexes
HUE035694T2 (en) 2012-10-12 2018-05-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
JP6307519B2 (en) 2012-12-21 2018-04-04 メドイミューン・リミテッドMedImmune Limited Pyrrolo benzodiazepines and its conjugate
JP2016505586A (en) 2012-12-21 2016-02-25 スパイロジェン・エス・アー・エール・エルSpirogen Sarl Asymmetric pyrrolobenzodiazepine dimer for use in the treatment of proliferative diseases and autoimmune diseases
US20160010140A1 (en) 2013-02-28 2016-01-14 Nichirei Biosciences, Inc. Dab-containing substrate kit for dyeing use which is produced using labelling enzyme
KR20150131203A (en) 2013-03-13 2015-11-24 메디뮨 리미티드 Pyrrolobenzodiazepines and conjugates thereof
BR112015021965A2 (en) 2013-03-13 2017-07-18 Medimmune Ltd pyrrolobenzodiazepines and conjugates thereof
US20160031887A1 (en) 2013-03-13 2016-02-04 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
CN105636612A (en) 2013-08-12 2016-06-01 基因泰克公司 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
WO2015095212A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
WO2015052532A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
BR112016013861A2 (en) 2013-12-16 2017-10-10 Genentech Inc antibody and conjugated drug, compound, method of treatment and pharmaceutical composition
MX2016007825A (en) 2013-12-16 2016-09-07 Genentech Inc Peptidomimetic compounds and antibody-drug conjugates thereof.
WO2016037644A1 (en) 2014-09-10 2016-03-17 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
US10149913B2 (en) 2014-09-12 2018-12-11 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
JP2017531620A (en) 2014-09-12 2017-10-26 ジェネンテック, インコーポレイテッド Cysteine ​​engineered antibodies and conjugates
BR112017005393A2 (en) 2014-09-17 2017-12-05 Genentech Inc compound of formula I, the method of preparation of a conjugate of formula, formula A1 conjugate, composition comprising a mixture of antibody-drug conjugate compounds, pharmaceutical composition and use of a conjugate or a composition
AU2015358532A1 (en) 2014-12-03 2017-06-29 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
US10058613B2 (en) 2015-10-02 2018-08-28 Genentech, Inc. Pyrrolobenzodiazepine antibody drug conjugates and methods of use
EP3362100A1 (en) 2015-10-16 2018-08-22 Genentech, Inc. Hindered disulfide drug conjugates
WO2017068511A1 (en) 2015-10-20 2017-04-27 Genentech, Inc. Calicheamicin-antibody-drug conjugates and methods of use
CN108700598A (en) 2016-03-25 2018-10-23 豪夫迈·罗氏有限公司 Multiplexed total antibody and antibody-conjugated drug quantification assay
EP3458101A1 (en) 2016-05-20 2019-03-27 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
EP3465221A1 (en) 2016-05-27 2019-04-10 H. Hoffnabb-La Roche Ag Bioanalytical method for the characterization of site-specific antibody-drug conjugates
US20170348422A1 (en) 2016-06-06 2017-12-07 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
WO2018031662A1 (en) 2016-08-11 2018-02-15 Genentech, Inc. Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
WO2018065501A1 (en) 2016-10-05 2018-04-12 F. Hoffmann-La Roche Ag Methods for preparing antibody drug conjugates
WO2019060398A1 (en) 2017-09-20 2019-03-28 Ph Pharma Co., Ltd. Thailanstatin analogs

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919638A (en) 1996-10-08 1999-07-06 Abbott Laboratories Reagents and methods useful for detecting prostate tumors
US5885776A (en) * 1997-01-30 1999-03-23 University Of Iowa Research Foundation Glaucoma compositions and therapeutic and diagnositic uses therefor
IL131560D0 (en) * 1997-02-25 2001-01-28 Corixa Corp Compounds for immunotherapy of prostate cancer and methods for their use
US6194152B1 (en) * 1997-08-20 2001-02-27 Dendreon Corporation Prostate tumor polynucleotide compositions and methods of detection thereof
WO2000040614A2 (en) 1998-12-30 2000-07-13 Beth Israel Deaconess Medical Center, Inc. Characterization of the soc/crac calcium channel protein family
US6534642B1 (en) * 1999-07-09 2003-03-18 Matthias A. Hediger Compositions corresponding to a calcium transporter and methods of making and using same
WO2001014423A1 (en) 1999-08-19 2001-03-01 Smithkline Beecham P.L.C. Identification of three putative calcium channel vanilrep peptides
AU2074201A (en) 1999-12-08 2001-06-18 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU3447401A (en) 2000-01-14 2001-07-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20020072101A1 (en) * 2000-01-21 2002-06-13 Gaughan Glen T. Novel human nucleic acid molecules and polypeptides encoding cation channels
US20020142377A1 (en) * 2000-02-22 2002-10-03 Glucksmann Maria Alexandra 18607, a novel human calcium channel
WO2001068857A2 (en) 2000-03-15 2001-09-20 Millennium Pharmaceuticals, Inc. 18615 and 48003, human ion channels and uses therefor
US20020156253A1 (en) 2000-06-26 2002-10-24 Curtis Rory A.J. 48000 and 52920, novel human calcium channels and uses thereof
WO2002014361A2 (en) * 2000-08-17 2002-02-21 Agensys, Inc. NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
MXPA03003151A (en) 2000-10-13 2003-08-19 Eos Biotechnology Inc Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer.

Also Published As

Publication number Publication date
AU8763901A (en) 2002-02-13
WO2002010382A9 (en) 2002-09-19
WO2002010382A3 (en) 2003-10-09
WO2002010382A2 (en) 2002-02-07
EP1366158A2 (en) 2003-12-03
EP1366158B1 (en) 2008-05-21
CA2417671A1 (en) 2002-02-07
JP2004505617A (en) 2004-02-26
DE60134178D1 (en) 2008-07-03
US7205108B2 (en) 2007-04-17
US20040072998A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
DE60122708D1 (en) Zero-click
DE60111771D1 (en) Mikroklingeanordungsaufprallapplikator
DE60013305D1 (en) Perkolationsvorrichtung
DE60112945D1 (en) Schädelkalottenfixiereinrichtung
DE60116715D1 (en) Ablationskartierungskatheter
DE60110402D1 (en) Strukturverbaupanele
DE60024877D1 (en) Elektrokauterisationskatheter
DE60100996D1 (en) Biarylcarboxamide
DE60113289D1 (en) Schergelzusammensetzungen
DE50107313D1 (en) Lichtleitfaserverbindungsgehäuse
DE60112184D1 (en) Ejektorzyklus
DE60119808D1 (en) Fahrradantriebsnabe
DE60121343D1 (en) Lotterielosaktionsspiel
DE50111625D1 (en) Seitenblinkleuchte
DE60113503D1 (en) Anti-kickback-catheter
DE60107957D1 (en) Flüssigkeitssprühgeräte
DE60118634D1 (en) Biodatenschnittstellensystem
DE60043512D1 (en) Epoxyalkoxysiloxanoligomere
DE60116267D1 (en) positioning
AT532452T (en) Analytüberwachungsgerät
AT556670T (en) Filterabgabe- and -rückbringvorrichtung
AT373443T (en) Analytensensor
AT368659T (en) Thrombinrezeptorantagonisten
AT415857T (en) Lichtleitersondenplatzierhilfe
AT272996T (en) Kieselsäureester-mixtures

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties